IBCSG 23-01 Sentinel Node Biopsy Trial

Phase 3

• Conditions: Adjuvant Breast Cancer; Cancer - Breast

• Registration Number: ACTRN12605000360617
• Lead Sponsor: Breast Cancer Trials

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-09
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Stopped early
• Sex: Female
• Target Recruitment: 1960

Inclusion Criteria

Patients of any age with pathological diagnosis of unifocal breast carcinoma with micrometastases in the sentinel node, who have completed baseline Quality of Life evaluations, and geographically accessible for follow up and who have signed written informed consent.

Exclusion Criteria

Patients with clinical evidence of distant metastases; palpable axillary nodes; Pagets disease without invasive cancer; patients who have received a chemoprevention agent within a year of randomization; patients who are pregnant or lactating; patients with previous or concomitant malignancy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified